Skip to main content
Log in

A comparative study of dihydroartemisinin compounds in treatment of uncomplicated falciparum malaria in Kampong of Cambodia

  • Original Articles
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective: To compare the safety and efficacy of two compounds of dihydroartemisinin (DHA)—Artekin and Artekin (T) in the treatment of uncomplicated falciparum malaria.Methods: The regimen of 8-tablet for 2 days of Artekin and Artekin (T) were applied to 100 patients with uncomplicated falciparum malaria, who were randomly divided into two groups. Each group contained 50 cases. The cure rate, the mean parasites clearance time, the mean fever clearance and side-effects were observed to assess the safety and efficacy of the compounds used.Results: The mean parasites clearance time was 31.7±9.0 hours in the Artekin group and 32.8±8.8 hours in Artekin (T) group respectively; the mean fever clearance time was 12. 7±7. 2 hours in Artekin group and 16. 5±7. 9 hours in Artekin (T) group; there were no recrudescence case in both groups within the 28 days of follow-up, the cure rates in Artekin group and Artekin (T) groups were 100%. It indicated that the tolerability of both compounds were very good, the side-effects such as nausea, abdominal pain were mild and self-limited.Conclusion: The study preliminarily indicated that the DHA and PQ compounds were of high efficacy, rapid acting and low toxicity. Artekin is very promising as a cheap, simple, effective treatment for multi-resistance malaria in Cambodia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mclntosh HM, Greenwood BM. Chloroquine or Amodiaquine combinated with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria—a systematic review. Ann Tropical Medicine Parasitology 1998; 93: 265–270.

    Google Scholar 

  2. Mockenhaupt FP. Mefloquine resistance in Plasmodium falciparum. Parasitol Today 1995; 11: 248–253.

    Article  PubMed  CAS  Google Scholar 

  3. WHO (1973) Chemotherapy of malaria and resistance to antimalaria. Report of a WHO scientific working group. WHO Tech. Rep, ser 1973;529: 30.

    Google Scholar 

  4. WHO. The World Health Report. WHO Geneva 1998: 184.

  5. RingWald P, Bickii J, Basco L. Randomized trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 1996; 347: 24–28.

    Article  PubMed  CAS  Google Scholar 

  6. Sowunmi A, Odupla AMJ. Open comparison of mefloquine, mefloquine/sulfadoxine/ pyrimethamine and choroquine in acute uncomplicated falciparum malaria in children. Trans R Soc Trop Med Hyg 1995; 89: 303–305.

    Article  PubMed  CAS  Google Scholar 

  7. Nosten F, Ter Kuile Fo, Chongsuphajaisiddhi T, et al. Melfoquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 1991; 337: 1140–1143.

    Article  PubMed  CAS  Google Scholar 

  8. Pukritt Ayakamee S, Supanaranonnd S, Looareesuwan S, et al. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Tran R Soc Trop Med Hyg 1994; 88: 488–491.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Song Jian-ping.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jian-ping, S., Socheat, D. & Seila, S. A comparative study of dihydroartemisinin compounds in treatment of uncomplicated falciparum malaria in Kampong of Cambodia. Chin. J. Integr. Med. 9, 31–34 (2003). https://doi.org/10.1007/BF02836350

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02836350

Key words

Navigation